Objective: Burn injury is a type of injury which is the disruptin of skin and organs by the effects of heat, electrical current, chemical caustic or burning agents. The purposes of daily burn care are removing of necrotic tissue, prevention of bacterial contamination, control of travma, stimulation of epithelization and protection of systemic complications. In this study, the effects of hyperbaric oxygen and ozone therapy were investigated, and used as adjuvant therapy in burn management, on burned areas utilizing experimental burn model. Material and Methods: In this study, 28 Wistar albino rats weighing 200-220 gr were used and divided into four groups. 10% burn defect areas were occured in all experiments. In the first group, rats were treated with hyperbaric oxygen. Medical ozone therapy was applied to the second group. In the third group, only debridement was used as treatment. Any treatment options were not used to rats in the fourth group. Results: The analysis revealed no statistically significant difference of burns surface areas between Groups 1 and 2, while a significant reduction were noted in Groups 1 and 2 when compared to the other groups. On histopathologic examination of the Groups 1 and 2 we observed a significant decrease in the inflammation and fibrosis rates when compared with other groups. Conclusion: As a result, we observed the affirmative effects of hyperbaric oxygen and ozone therapy on burn management. We suggest that these treatment modalities can be added to standart treatment options as adjuvant therapy. We also think that large researches are needed to support this issue.
Keywords: Hyperbaric oxygen; medical ozone; burns
Amaç: Yanık hasarı; derinin veya organların ısı, elektrik akımı, kimyasal veya yakıcı bir ajan etkisi ile tahrip olması şeklinde gerçekleşen bir yaralanma şeklidir. Günlük yanık bakımının hedefleri nekrotik dokuları kaldırmak, bakteriyel kontaminasyonu önlemek, travmayı kontrol etmek, epitelizasyonu uyarmak ve sistemik komplikasyonlardan korunmaktır. Bu çalışmada; deneysel yanık modelinde, adjuvan tedavi olarak kullanılan hiperbarik oksijen ve medikal ozon tedavilerinin etkileri incelenmiştir.Gereç ve Yöntemler: Çalışmaya, ağırlıkları 200-220 gr. ağırlığında 28 adet Wistar albino sıçan dahil edildi ve 4 deney grubu oluşturuldu. Tüm deneklerde %10 yanık yüzey alanı meydana getirildi. Birinci grup hiperbarik oksijen tedavisi aldı. İkinci gruba medikal ozon tedavisi uygulandı. Üçüncü gruba sadece debridman uygulandı. Dördüncü gruptaki sıçanlara ise herhangi bir tedavi uygulanmadı. Bulgular: Grup 1 ve 2 arasında yanık yüzey alanı açısından istatistiksel açıdan anlamlı bir farklılık gözlenmez iken, Grup 1 ve 2 ile diğer gruplar arasında anlamlı derecede azalma gözlendi. Histopatolojik incelemede Grup 1 ve 2'de, diğer gruplara kıyasla inflamasyon ve fibrosis oranlarında belirgin azalma gözlendi. Sonuç: Sonuç olarak, yanık tedavisinde hiperbarik oksijen ve medikal ozon tedavisinin yararlı etkileri olduğunu gözlemledik. Bu tedavilerin standart yanık tedavisine ek olarak uygulanabileceğini düşünmekteyiz. Ancak, bu konuda geniş çaplı araştırmaların yapılması gerektiği kanaatindeyiz.
Anahtar Kelimeler: Hiperbarik oksijen; medikal ozon; yanık
- Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing--review of the literature. Burns. 2005;31(8):944-56.[Crossref] [PubMed]
- Whitney JD, Wickline MM. Treating chronic and acute wounds with warming: review of the science and practice implications. J Wound Ostomy Continence Nurs. 2003;30(4):199-209.[Crossref] [PubMed]
- Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29(1):4-30.[PubMed]
- Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37(4):425-35.[Crossref] [PubMed]
- Shoshani O, Shupak A, Barak A, Ullman Y, Ramon Y, Lindenbaum E, et al. Hyperbaric oxygen therapy for deep second degree burns: an experimental study in the guinea pig. Br J Plast Surg. 1998;51(1):67-73.[Crossref] [PubMed]
- Cianci P, Slade Jr JB, Sato RM, Faulkner J. Adjunctive hyperbaric oxygen therapy in the treatment of thermal burns. Undersea Hyperb Med. 2013;40(1):89-108.[PubMed]
- Nylander G, Nordström H, Eriksson E. Effects of hyperbaric oxygen on oedema formation after a scald burn. Burns Incl Therm Inj. 1984;10(3):193-6.[Crossref] [PubMed]
- Villanueva E, Bennett MH, Wasiak J, Lehm JP. Hyperbaric oxygen therapy for thermal burns. Cochrane Database Syst Rev. 2004;(3):CD004727.[Crossref] [PubMed]
- Guven A, Gundogdu G, Sadir S, Topal T, Erdogan E, Korkmaz A, et al. The efficacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg. 2008;43(9):1679-84.[Crossref] [PubMed]
- Chantre C, Foucher S, Le Hot H, Lefort H, Blatteau JÉ. [Hyperbaric oxygen therapy, a little-known discipline]. Rev Infirm. 2018;67(242):14-5.[Crossref] [PubMed]
- MacFarlane C, Cronje FJ, Benn CA. Hyperbaric oxygen in trauma and surgical emergencies. J R Army Med Corps. 2000;146(3):185-90.[Crossref] [PubMed]
- Niezgoda JA. Hyperbaric oxygen therapy: panorama of perspectives. Adv Skin Wound Care. 2017;30(4):150.[Crossref] [PubMed]
- Magri K, Bigeni S, Azzopardi CP, Camilleri L, Matity L, Muscat S, et al. Hyperbaric oxygen therapy awareness within a doctor population. Undersea Hyperb Med. 2020;47(1):39-50.[Crossref] [PubMed]
- Bennett MH. Hyperbaric medicine and the placebo effect. Diving Hyperb Med. 2014;44(4):235-40.[PubMed]
- Sepehripour S, Dhaliwal K, Dheansa B. Hyperbaric oxygen therapy and intermittent ischaemia in the treatment of chronic wounds. Int Wound J. 2018;15(2):310.[Crossref] [PubMed]
- Perdrizet GA, Gould LJ, Deciantis C, Zinno RP. The Kent Hospital wound recovery and hyperbaric medicine center: a brief overview, 1998-2013. R I Med J (2013). 2014;97(4):13-7.[PubMed]
- Kot J, Mathieu D. Controversial issues in hyperbaric oxygen therapy: a European Committee for Hyperbaric Medicine Workshop. Diving Hyperb Med. 2011;41(2):101-4.[PubMed]
- Kot J, Desola J, Simao AG, Gough-Allen R, Houman R, Meliet JL, et al. A European code of good practice for hyperbaric oxygen therapy. Int Marit Health. 2004;55(1-4):121-30.[PubMed]
- Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: preliminary report. Diving Hyperb Med. 2016;46(2):122-3.[PubMed]
- Cooper JS, Allinson P, Keim L, Sisson J, Schuller D, Sippel J, et al. Hyperbaric oxygen: a useful adjunct for purpura fulminans: case report and review of the literature. Undersea Hyperb Med. 2014;41(1):51-7.[PubMed]
- Kirby JP. Hyperbaric oxygen therapy as an elective treatment. Mo Med. 2019;116(3):184-7.[PubMed]
- Lam G, Fontaine R, Ross FL, Chiu ES. Hyperbaric oxygen therapy: exploring the clinical evidence. Adv Skin Wound Care. 2017;30(4):E1.[Crossref] [PubMed]
- Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97(7):385-95.[Crossref] [PubMed]
- Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004;(2):CD004123.[Crossref] [PubMed]
- Zhao LL, Davidson JD, Wee SC, Roth SI, Mustoe TA. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg. 1994;129(10):1043-9.[Crossref] [PubMed]
- Lang TC, Zhao R, Kim A, Wijewardena A, Vandervord J, Xue M, et al. A critical update of the assessment and acute management of patients with severe burns. Adv Wound Care (New Rochelle). 2019;8(12):607-33.[Crossref] [PubMed] [PMC]
- Howell RS, Criscitelli T, Woods JS, Gillette BM, Gorenstein S. Hyperbaric oxygen therapy: indications, contraindications, and use at a tertiary care center: 1.3 www.aornjournal.org/content/cme. AORN J. 2018;107(4):442-53.[Crossref] [PubMed]
- Niinikoski JHA. Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World J Surg. 2004;28(3):307-11.[Crossref] [PubMed]
- Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004;13(1):3-11.[Crossref] [PubMed] [PMC]
- Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol. 2018;56:235-41.[Crossref] [PubMed]
- Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64(1):44-9.[Crossref] [PubMed]
- Velano HE, do Nascimento LC, de Barros LM, Panzeri H. [In vitro assessment of antibacterial activity of ozonized water against Staphylococcus aureus]. Pesqui Odontol Bras. 2001;15(1):18-22.[Crossref] [PubMed]
- Hartman DF, Goode RL. Pharmacologic enhancement of composite graft survival. Arch Otolaryngol Head Neck Surg. 1987;113(7):720-3.[Crossref] [PubMed]
- Yamanel L, Kaldirim U, Oztas Y, Coskun O, Poyrazoglu Y, Durusu M, et al. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. Int J Med Sci. 2011;8(1):48-55.[Crossref] [PubMed]
- Lewis D, Goldztein H, Deschler D. Use of hyperbaric oxygen to enhance auricular composite graft survival in the rabbit model. Arch Facial Plast Surg. 2006;8(5):310-3.[Crossref] [PubMed]
- Koca K, Yurttas Y, Bilgic S, Cayci T, Topal T, Durusu M, et al. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats. J Surg Res. 2010;164(1):e83-9.[Crossref] [PubMed]
- Al-Dalain SM, Martínez G, Candelario-Jalil E, Menéndez S, Re L, Giuliani A, et al. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001;44(5):391-6.[Crossref] [PubMed]
- Uysal B, Yasar M, Ersoz N, Coskun O, Kilic A, Cayc T, et al. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010;39(1):9-15.[Crossref] [PubMed]
- Altinel O, Demirbas S, Cakir E, Yaman H, Ozerhan IH, Duran E, et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest. 2011;71(3):185-92.[Crossref] [PubMed]
- Verrazzo G, Coppola L, Luongo C, Sammartino A, Giunta R, Grassia A, et al. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease. Undersea Hyperb Med. 1995;22(1):17-22.[PubMed]
.: İşlem Listesi